OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2021
(5)
2017
(5)
2025
(4)
2019
(3)
2020
(2)
2011
(2)
2023
(1)
2022
(1)
2018
(1)
2015
(1)
2014
(1)
2013
(1)
2010
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Organizational Challenges of Development and Implementation of Virtual Reality Solution for Industrial Operation.
Not available
S-EPMC8492956
|
biostudies-literature
Cite
Using electrophysiological measures to evaluate the sense of presence in immersive virtual environments: An event-related potential study.
Not available
S-EPMC8413821
|
biostudies-literature
Cite
Destruction complex dynamics: Wnt/β-catenin signaling alters Axin-GSK3β interactions
in vivo
.
Not available
S-EPMC6633605
|
biostudies-literature
Cite
Multiplex Competition, Collaboration, and Funding Networks Among Health and Social Organizations: Toward Organization-based HIV Interventions for Young Men Who Have Sex With Men.
Not available
S-EPMC5233557
|
biostudies-literature
Cite
An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.
Not available
S-EPMC5320866
|
biostudies-literature
Cite
A phase 2 study of vorinostat in acute myeloid leukemia.
Not available
S-EPMC2754953
|
biostudies-literature
Cite
Psilocybin's acute and persistent brain effects: a precision imaging drug trial.
Not available
S-EPMC12141498
|
biostudies-literature
Cite
Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma.
Not available
S-EPMC5656536
|
biostudies-literature
Cite
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.
Not available
S-EPMC3901994
|
biostudies-literature
Cite
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance).
Not available
S-EPMC6306886
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets